Dendreon to Present at Piper Jaffray Healthcare Conference

Dendreon to Present at Piper Jaffray Healthcare Conference 


SEATTLE, Jan. 21  /PRNewswire-FirstCall/ -- Dendreon Corporation (NASDAQ: DNDN)
today announced that management will present at the Piper Jaffray 17th Annual
Healthcare Conference in New York on Thursday, January 27, 2005 at 3:00 pm EST,
12:00 pm PST.  A live webcast of the presentation can be accessed by visiting
Dendreon's website http://www.dendreon.com/ under the "Investor/Webcasts &
Presentations" section or http://www.piperjaffray.com/hcwebcast.  A replay of
the presentation will be available for 30 days after the conference.

Dendreon Corporation is a biotechnology company whose mission is to target
cancer and transform lives through the development of innovative cancer
treatments. In addition to its immunotherapies in clinical and preclinical
development for a variety of cancers, Dendreon's product pipeline also includes
monoclonal antibody and small molecule product candidates. Dendreon has
research and development alliances with Genentech, Inc., Abgenix, Inc. and Dyax
Corp. For more information about the company and its programs, visit
http://www.dendreon.com/.

NOTE:  Except for historical information contained herein, this news release
contains forward-looking statements that are subject to risks and uncertainties
that may cause actual results to differ materially from the results discussed
in the forward-looking statements, particularly those risks and uncertainties
inherent in the process of discovering, developing and commercializing drugs
that are safe and effective for use as human therapeutics. Further information
on the factors and risks that could affect Dendreon's business, financial
condition and results of operations are contained in Dendreon's filings with
the U.S. Securities and Exchange Commission (SEC), which are available at
http://www.sec.gov/. 

DATASOURCE: Dendreon Corporation



CONTACT:  Monique M. Greer, Sr. Director, Corporate Communications of

Dendreon Corporation, [phone] 



Web site:  http://www.dendreon.com/ 

Copyright